| Literature DB >> 35681832 |
Alessandro Vastolo1, Jonathan Riedmüller2, Monica Isabella Cutrignelli1, Jürgen Zentek2.
Abstract
Lipids represent a significant energy source in dogs' diets. Moreover, dogs need some essential fatty acids, such as linoleic and α-linolenic fatty acids, because they are not able to produce them endogenously. This study aimed to evaluate the effect of different dietary lipid sources on faecal microbial populations and activities using different evaluations. Hemp seed oil and swine tallow were tested as lipid supplements in a commercial canned diet at a ratio of 3.5% (HL1 and HL2, respectively). These diets were compared with one rich in starch (HS). Twelve dogs were recruited and equally divided into three groups. Faeces samples at 30 days were used as inoculum and incubated with three different substrates (MOS, inulin, and cellulose) using the in vitro gas production technique. The faecal cell numbers of relevant bacteria and secondary metabolites were analysed (in vivo trial). In vitro evaluation showed that the faeces of the group fed the diet with hemp supplementation had better fermentability despite lower gas production. The in vivo faecal bacterial count showed an increase in Lactobacillus spp. In the HL1 group. Moreover, a higher level of acetate was observed in both evaluations (in vitro and in vivo). These results seem to indicate a significant effect of the dietary fatty acid profile on the faecal microbial population.Entities:
Keywords: Lactobacillus; bacteria; faecal inoculum; fatty acids profile; hemp; in vitro fermentation; inulin; tallow; volatile fatty acids
Year: 2022 PMID: 35681832 PMCID: PMC9179278 DOI: 10.3390/ani12111368
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 3.231
Chemical composition of the tested diet (g/1000 kcal ME).
| Diets | HS | HL1 | HL2 |
|---|---|---|---|
| ME (kcal/kg) | 1194 | 1286 | 1370 |
| CP | 74.3 | 89.6 | 77.0 |
| CF | 9.29 | 27.4 | 21.8 |
| EE | 30.9 | 55.1 | 65.1 |
| Ash | 27.9 | 28.8 | 23.0 |
| NFE | 136 | 62.2 | 50.7 |
HS: high starch; HL1: high lipid hemp; HL2: high lipid tallow. CP: crude protein; CF: crude fibre; EE: ether extract; NFE: nitrogen-free extract.
Fatty acid profiles of the test diets administered to dogs (mg/1000 kcal ME).
| Fatty Acids | HS | HL1 | HL2 |
|---|---|---|---|
| C4:0 | 1.72 | 4.35 | 4.18 |
| C6:0 | 0.37 | 3.86 | 3.21 |
| C8:0 | 0.02 | 0.24 | 0.08 |
| C10:0 | 0.04 | ND | 0.08 |
| C12:0 | 0.22 | ND | 0.26 |
| C14:0 | 1.05 | 1.29 | 3.51 |
| C16:0 | 11.4 | 28.8 | 47.0 |
| C16:1 | ND | 0.35 | 0.32 |
| C18:1 cis6 | 0.12 | 0.14 | 0.50 |
| C18:0 | 4.60 | 25.0 | 31.3 |
| C18:1 trans 11 (TVA) | 0.51 | 3.09 | 2.45 |
| C18:1 cis 9 | 19.0 | 46.3 | 71.1 |
| C18:1 cis 10 | 0.08 | 0.62 | 0.57 |
| C18:1 cis 11 | 0.008 | 0.02 | 0.04 |
| C18:2 cis n-6 (LA) | 9.82 | 34.0 | 19.8 |
| C20:0 | 0.08 | 0.61 | 0.37 |
| C18:3 n-6 | 0.02 | 0.37 | 0.96 |
| C18:3 n-3 (ALA) | 0.95 | 5.75 | 2.59 |
| C20:2 n-6 | 0.05 | 0.24 | 0.63 |
| C22:0 | 0.14 | 0.26 | 2.23 |
| C20:3 n-6 | 0.03 | 0.06 | 0.07 |
| C22:1 | 0.02 | ND | 0.18 |
| C20:3 n-3 | 0.11 | 0.99 | 0.45 |
| C20:4 n-6 (AA) | 0.15 | 0.20 | 0.35 |
| C22:2 n-6 | 0.19 | 0.13 | 0.58 |
| C24:0 | 0.03 | 0.09 | 0.18 |
| C20:5 n-3 (EPA) | 0.008 | 0.29 | 0.09 |
| SFA | 38.8 | 173 | 103 |
| MCT | 2.37 | 8.45 | 7.81 |
| MUFA | 20.2 | 81.1 | 48.7 |
| PUFA | 11.3 | 27.2 | 17.7 |
| n-6 | 10.3 | 23.9 | 15.7 |
| n-3 | 1.07 | 3.33 | 2.03 |
| PUFA/SFA | 0.29 | 0.16 | 0.17 |
| n-6/n-3 | 9.58 | 7.17 | 7.73 |
| LA/ALA | 10.3 | 5.93 | 7.65 |
| AA/EPA | 18.0 | 0.70 | 4.00 |
HS: high starch; HL1: high lipid hemp; HL2: high lipid tallow. ND: not detectable; C4:0: butyric acid; C6:0: caproic acid; C8:0: caprylic acid; C14:0: myristic acid; C16:0: palmitic acid; C18:1 cis6: petroselinic acid; C18:0: stearic acid; C18:1 trans 11: trans vaccenic acid (TVA); C18:1 cis 9: oleic acid; C18:2 cis n-6: linoleic acid (LA); C20:0: arachidic acid; C18:3 n-6: γ-linolenic acid (GLA); C18:3 n-3: α-linoleic acid (ALA); C20:2 n-6: eicosadienic acid; C22:0: behenic acid; C20:3 n-6; C20:3: n-3: dihomo γ-linolenic; C20:4 n-6: arachidonic acid(AA); C22:2 n-6: docosadienoic acid; C24:0: lignoceric acid; C20:5 n-3: eicosapentenoic (EPA); SFAs: saturated fatty acids; MCT: medium chain triglycerides (C6:0 + C8:0 + C10:0 + C12:0); MUFAs: monounsaturated fatty acids; PUFAs: polyunsaturated fatty acids; LA/ALA: linoleic acid/α-linolenic acid; AA/EPA: arachidonic acid/eicosapentaenoic acid.
PCR characteristics and primers used to assess bacterial cell numbers in dog faeces.
| Specificity | Sequence | Name | Product. bp | AT 1 | Reference |
|---|---|---|---|---|---|
| F:5′-AGCAGTAGGGAATCTTCCA-3′ | LAC-1 | 341 | 58 | Rinttilä et al. [ | |
| Enterobacteria | F:5′-GTTAATACCTTTGCTCATTGA-3 | Entero-F | 340 | 50 | Malinen et al. [ |
| F:5′-TCGCGTC(C/T)GGTGTGAAAG-3′ | g-BIFID-F | 243 | 58 | Rinttilä et al. [ | |
| AAATGACGGTACCTGACTAA | g-Cocc-F | 440 | 55 | Matsuki et al. [ | |
| GCACAAGCAGTGGAGT | sg-Clept-F | 239 | 55 | Matsuki et al. [ |
AT 1 = annealing temperature (°C).
Organic matter degradability and in vitro gas production parameters of groups’ pooled faeces after 24 h of incubation.
| Items | OMD | OMCV |
|---|---|---|
| % | mL/g | |
| HS-group | 57.2 B | 51.1 A |
| HL1-group | 60.1 A | 40.8 B |
| HL2-group | 58.6 B | 58.2 A |
| Substrate effect | ||
| MOS | 97.5 A | 24.8 B |
| Inulin | 76.4 B | 114 A |
| Cellulose | 2.02 C | 10.8 C |
| *** | *** | |
| MSE | 1.64 | 46.1 |
HS: high starch; HL1: high lipid hemp; HL2: high lipid tallow. MOS: mannan-oligosaccharides; OMD: organic matter degradability; OMCV: cumulative volume related to incubated organic matter. Along the column, different capital superscript letters indicate a difference at p < 0.01; ***: p 0.01 < 0.MSE: mean square error.
In vitro end-products at 24 h of incubation.
| Items | pH | VFA | Acetate | Propionate | Iso-Butyrate | Butyrate | Iso-Valerate | Valerate | BCFA |
|---|---|---|---|---|---|---|---|---|---|
| mmol/gOM | % VFA | ||||||||
| HS-group | 6.27 | 53.4 B | 45.6 C | 23.9 A | 3.45 | 19.6 A | 5.08 A | 1.87 B | 8.53 a |
| HL1-group | 6.18 | 43.2 C | 53.2 A | 22.6 B | 3.06 | 16.2 B | 4.81 A | 0.91 C | 7.88 ab |
| HL2-group | 6.26 | 72.3 A | 50.2 B | 16.8 C | 3.19 | 19.3 A | 4.15 B | 2.27 A | 7.34 b |
| Substrate effect | |||||||||
| MOS | 6.42 B | 65.6 B | 49.9 B | 21.4 B | 3.11 B | 19.4 B | 4.51 B | 1.75 B | 7.62 B |
| Inulin | 5.45 C | 74.7 A | 43.9 C | 26.1 A | 1.04 C | 22.9 A | 1.47 C | 0.62 C | 2.51 C |
| Cellulose | 6.83 A | 28.5 C | 55.2 A | 16.7 C | 5.55 A | 12.9 C | 8.07 A | 2.69 A | 13.6 A |
| NS | *** | *** | *** | NS | *** | *** | *** | *** | |
| MSE | 0.08 | 12.4 | 4.47 | 1.17 | 0.22 | 5.60 | 0.33 | 0.07 | 0.96 |
HS: high starch; HL1: high lipid hemp; HL2: high lipid tallow. MOSs: mannan-oligosaccharides; VFAs: volatile fatty acids; BCFAs: branched-chain fatty acids. Along the column, different capital superscript letters indicate a difference for p < 0.01; lowercase superscript letters indicate a difference for p < 0.05. *** p < 0.001, NS: not significant; MSE: mean square error.
Faecal bacterial cell evaluation of dogs fed the administered diets (log/g sample wet weight).
| Bacteria Cell Count | HS | HL1 | HL2 | ||
|---|---|---|---|---|---|
| Between Diets | HL1 vs. HL2 | ||||
| 6.86 ± 0.22 | 7.11 ± 0.05 | 6.55 ± 0.14 | 0.0429 | 0.0142 | |
| 2.54 ± 0.29 | 2.60 ± 0.21 | 2.20 ± 0.11 | 0.6376 | 0.2008 | |
| Enterobacteria | 6.01 ± 0.22 | 6.91 ± 0.10 | 6.66 ± 0.13 | 0.0131 | 0.1594 |
| 9.95 ± 0.03 | 9.86 ± 0.04 | 9.77 ± 0.05 | 0.0203 | 0.1821 | |
| 8.53 ± 0.09 | 8.05 ± 0.22 | 8.57 ± 0.10 | 0.1874 | 0.1408 | |
HS: high starch; HL1: high lipid hemp; HL2: high lipid tallow. Cl: Clostridium.
Volatile fatty acids (VFAs) present in the dogs’ faeces.
| Items | Units | HS | HL1 | HL2 | ||
|---|---|---|---|---|---|---|
| Between Diets | HL1 vs. HL2 | |||||
| VFA (mmol/g) | 163 ± 6.52 | 87.2 ± 2.98 | 134 ± 9.97 | 0.0024 | 0.0105 | |
| acetate | % VFA | 60.6 ± 0.40 | 61.4 ± 0.82 | 58.7 ± 0.53 | 0.0221 | 0.0209 |
| propionate | % VFA | 28.2 ± 0.42 | 25.9 ± 0.45 | 23.1 ± 0.50 | 0.0001 | 0.0033 |
| iso-butyrate | % VFA | 1.03 ± 0.07 | 1.31 ± 0.12 | 2.34 ± 0.06 | 0.0003 | 0.0008 |
| butyrate | % VFA | 8.11 ± 0.28 | 10.5 ± 0.43 | 9.40 ± 0.44 | 0.0035 | 0.0633 |
| iso-valerate | % VFA | 1.40 ± 0.08 | 1.21 ± 0.07 | 3.45 ± 0.14 | 0.0003 | 0.0008 |
| valerate | % VFA | 0.36 ± 0.02 | 0.30 ± 0.02 | 2.94 ± 0.11 | 0.0004 | 0.0012 |
| BCFA | % VFA | 2.07 ± 0.25 | 2.87 ± 0.36 | 5.51 ± 0.31 | 0.0003 | 0.0011 |
HS: high starch; HL1: high lipid hemp; HL2: high lipid tallow. BCFAs: branched-chain fatty acids; VFAs: total volatile fatty acids.
Contents of D-L-lactate, ammonia, and pH in the dogs’ faeces.
| Items | HS | HL1 | HL2 | ||
|---|---|---|---|---|---|
| Between Diets | HL1 vs. HL2 | ||||
| D-lactate (µL/g) | 1.67 ± 0.58 | 0.25 ± 0.03 | 0.43 ± 0.14 | 0.0138 | 0.6242 |
| L-lactate (µL/g) | 1.77 ± 0.82 | 0.22 ± 0.06 | 0.25 ± 0.14 | 0.0468 | 0.6473 |
| Ammonia (µmol/g) | 59.9 ± 4.80 | 42.7 ± 2.24 | 59.3 ± 5.46 | 0.0255 | 0.0472 |
| pH | 6.75 ± 0.06 | 6.97 ± 0.04 | 7.11 ± 0.03 | 0.0008 | 0.0273 |
HS: high starch; HL1: high lipid hemp; HL2: high lipid tallow.